Dr. Richard Paul Von Buedingen, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 191 Centre South Blvd, #20, Aiken, SC 29803 Phone: 803-648-7815 Fax: 803-648-8028 |
Jonathan Hal Anderson, M.D., F.A.C.S. Urology Medicare: Accepting Medicare Assignments Practice Location: 770 Medical Park Dr, Aiken, SC 29801 Phone: 803-649-3903 Fax: 803-642-6161 |
Dr. Darren Joseph Mack, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 770 Medical Park Dr, Aiken, SC 29801 Phone: 803-716-8712 Fax: 803-716-8713 |
News Archive
Caliper Life Sciences, Inc., a leading provider of products and services for drug discovery research, today announced that it has entered into a definitive agreement to acquire privately-held Cambridge Research & Instrumentation, Inc. (CRi) for approximately $20.0 million, including net debt. CRi's patented preclinical and tissue-based multiplexed analysis systems will expand Caliper's life sciences tools portfolio, particularly as it bridges into clinical research, pathology and clinical market applications.
A simple blood test may help prevent a serious complication associated with a contrast agent commonly used in MRI exams, according to a study published in the July issue of Radiology.
Standing for at least one-quarter of the day has been linked to lower odds of obesity in a new study led by the American Cancer Society in collaboration with The Cooper Institute, the University of Texas, and the University of Georgia.
Expanding Orthopedics Inc., a leading company in the area of expanding orthopedics devices, announced today that it has started to enroll patients in Germany for its multi-center post-market study to evaluate the performance and usability of the XPED Expanding Pedicle Screw System.
Two of the world's leading healthcare technology companies are joining forces to make possible the development of leading-edge solutions that will advance patient care around the world. Hill-Rom Holdings, Inc. and privately-held Welch Allyn, Inc. today announced that the Boards of Directors of both companies have unanimously approved a definitive agreement under which Hill-Rom will acquire Welch Allyn for approximately $2.05 billion in cash and stock.
› Verified 3 days ago